Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tongren Niuhuang Qingxin Pills
- Development stage
- Unknown
- Lead developer
- Beijing Tong Ren Tang
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Tongren Niuhuang Qingxin Pills (同仁牛黄清心丸) is a prominent Traditional Chinese Medicine (TCM) formula produced by Beijing Tong Ren Tang, based on a modified prescription from the Song Dynasty. It is a complex multi-ingredient formulation containing 27 substances, including Calculus Bovis (cow gallstone), Radix Ginseng, Rhizoma Dioscoreae, and Radix Scutellariae. Traditionally, it is used to clear heat, resolve phlegm, and calm the mind, with primary indications for dizziness, palpitations, and speech impairment following a stroke. Modern clinical research, including studies involving the Third Affiliated Hospital of Beijing University of Traditional Chinese Medicine, has explored its efficacy in treating generalized anxiety disorder (GAD) and insomnia. The pharmacological profile of the formula involves the modulation of neurotransmitter systems, specifically acting as a positive allosteric modulator of GABAergic pathways and regulating serotonin levels, which contributes to its anxiolytic and sedative properties.
- Brand names
- Tongren Niuhuang Qingxin Wan
- Other names
- Niuhuang Qingxin WanBovine Antelope Sedative Pill
02
Targets
GABA-B (Gamma-aminobutyric acid receptor type B)5-HT (Serotonin receptors)
Beyond the preview
Go deeper on Tongren Niuhuang Qingxin Pills.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tongren Niuhuang Qingxin Pills.